L. Pang

821 total citations
22 papers, 685 citations indexed

About

L. Pang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, L. Pang has authored 22 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in L. Pang's work include RNA and protein synthesis mechanisms (12 papers), RNA modifications and cancer (8 papers) and Biochemical and Molecular Research (3 papers). L. Pang is often cited by papers focused on RNA and protein synthesis mechanisms (12 papers), RNA modifications and cancer (8 papers) and Biochemical and Molecular Research (3 papers). L. Pang collaborates with scholars based in Belgium, China and United States. L. Pang's co-authors include Liying Ma, Arthur Van Aerschot, S.D. Weeks, Yi‐Chao Zheng, Hong‐Min Liu, Deng‐Qi Xue, Kun‐Peng Shao, Hong‐Min Liu, Miao Zhang and Biao Hu and has published in prestigious journals such as Chemical Engineering Journal, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

L. Pang

21 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Pang Belgium 12 411 318 70 62 40 22 685
Hidetoshi Shindoh United States 11 265 0.6× 204 0.6× 78 1.1× 46 0.7× 26 0.7× 17 568
Surender Mohan India 12 232 0.6× 107 0.3× 57 0.8× 40 0.6× 29 0.7× 23 450
Matthieu Desroses Sweden 15 423 1.0× 222 0.7× 67 1.0× 185 3.0× 23 0.6× 24 692
Naoyuki Asakawa Japan 13 245 0.6× 206 0.6× 114 1.6× 25 0.4× 28 0.7× 22 505
Mohamed Hagras Egypt 18 384 0.9× 512 1.6× 73 1.0× 108 1.7× 55 1.4× 40 818
Christine Latour France 17 152 0.4× 331 1.0× 66 0.9× 59 1.0× 28 0.7× 23 747
Michael Hale United States 13 329 0.8× 240 0.8× 66 0.9× 148 2.4× 16 0.4× 18 650
Sahar Kandil United Kingdom 12 188 0.5× 280 0.9× 30 0.4× 64 1.0× 10 0.3× 19 525
Junhai Xiao China 16 314 0.8× 157 0.5× 114 1.6× 39 0.6× 20 0.5× 61 634

Countries citing papers authored by L. Pang

Since Specialization
Citations

This map shows the geographic impact of L. Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pang more than expected).

Fields of papers citing papers by L. Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pang. The network helps show where L. Pang may publish in the future.

Co-authorship network of co-authors of L. Pang

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pang. A scholar is included among the top collaborators of L. Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pang. L. Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Chao, L. Pang, Xi Xiong, et al.. (2025). CuO2 and tannic acid mediated synergistic antimicrobial and antifouling coatings. Chemical Engineering Journal. 522. 167589–167589.
2.
Song, Mengqiu, et al.. (2023). Cdc2-like kinases: structure, biological function and therapeutic targets for diseases. Signal Transduction and Targeted Therapy. 8(1). 148–148. 35 indexed citations
3.
Pang, L., et al.. (2022). Partitioning of the initial catalytic steps of leucyl-tRNA synthetase is driven by an active site peptide-plane flip. Communications Biology. 5(1). 883–883. 3 indexed citations
4.
Shen, Dandan, Bo Wang, Ya Gao, et al.. (2022). Detailed resume of RNA m6A demethylases. Acta Pharmaceutica Sinica B. 12(5). 2193–2205. 59 indexed citations
5.
Pang, L., S.D. Weeks, Jef Rozenski, et al.. (2022). Structural Basis of Cysteine Ligase MshC Inhibition by Cysteinyl-Sulfonamides. International Journal of Molecular Sciences. 23(23). 15095–15095. 2 indexed citations
6.
Pang, L., S.D. Weeks, & Arthur Van Aerschot. (2021). Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery. International Journal of Molecular Sciences. 22(4). 1750–1750. 55 indexed citations
7.
Vondenhoff, Gaston, et al.. (2020). Synthesis and structural insights into the binding mode of the albomycin δ1 core and its analogues in complex with their target aminoacyl-tRNA synthetase. Bioorganic & Medicinal Chemistry. 28(17). 115645–115645. 4 indexed citations
8.
Pang, L., Jef Rozenski, Sergei V. Strelkov, et al.. (2020). Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase. Bioorganic & Medicinal Chemistry. 28(15). 115580–115580. 8 indexed citations
9.
Pang, L., Davie Cappoen, Paul Cos, et al.. (2020). Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors. European Journal of Medicinal Chemistry. 211. 113021–113021. 14 indexed citations
10.
Pang, L., Eveline Lescrinier, Jef Rozenski, et al.. (2020). Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors. Molecules. 25(20). 4751–4751. 2 indexed citations
11.
Pang, L., Valentina Zorzini, Anastassios Economou, et al.. (2019). Structural Insights into the Binding of Natural Pyrimidine-Based Inhibitors of Class II Aminoacyl-tRNA Synthetases. ACS Chemical Biology. 15(2). 407–415. 12 indexed citations
12.
Pang, L., Wim M. De Borggraeve, Jef Rozenski, et al.. (2019). Acylated sulfonamide adenosines as potent inhibitors of the adenylate-forming enzyme superfamily. European Journal of Medicinal Chemistry. 174. 252–264. 9 indexed citations
13.
Pang, L., et al.. (2019). Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases. European Journal of Medicinal Chemistry. 173. 154–166. 8 indexed citations
14.
Pang, L., et al.. (2019). Synthesis and Biological Evaluation of Lipophilic Nucleoside Analogues as Inhibitors of Aminoacyl-tRNA Synthetases. Antibiotics. 8(4). 180–180. 2 indexed citations
15.
Pang, L., Matheus Froeyen, Lieve Van Mellaert, et al.. (2018). Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases. European Journal of Medicinal Chemistry. 148. 384–396. 16 indexed citations
16.
Wang, Bo, Bing Zhao, L. Pang, et al.. (2017). LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1. Pharmacological Research. 122. 66–77. 27 indexed citations
17.
Wang, Bo, Bing Zhao, Zhe‐Sheng Chen, et al.. (2017). Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance. European Journal of Medicinal Chemistry. 143. 1535–1542. 47 indexed citations
18.
Ma, Liying, Bo Wang, L. Pang, et al.. (2015). Design and synthesis of novel 1,2,3-triazole–pyrimidine–urea hybrids as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 25(5). 1124–1128. 87 indexed citations
19.
Ma, Liying, L. Pang, Bo Wang, et al.. (2014). Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. European Journal of Medicinal Chemistry. 86. 368–380. 107 indexed citations
20.
Zhang, En, et al.. (2013). Design and synthesis of novel D-ring fused steroidal heterocycles. Steroids. 78(12-13). 1200–1208. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026